Skip to main content
Premium Trial:

Request an Annual Quote

Quebec Organizations Create $22M Personalized Medicine Center

NEW YORK (GenomeWeb News) – The Montreal Heart Institute and Génome Québec have formed the Center of Excellence in Personalized Medicine, which will be funded with more than $22 million in investments from government and commercial entities over five years, the partners announced Thursday.
Canada’s Centers of Excellence for Commercialization and Research program will provide $13.8 million of the total funding, with the remainder coming from private and public partners including the ministère du Développement économique, de l'Innovation et de l'Exportation of Québec.
The goal of the new center is to “develop approaches and methods that will optimize treatment and ensure their rapid and productive transition from the research stage to use in clinical practice,” according to a statement issued by the organizations.
The Montreal Heart Institute will house the new center, which was developed in collaboration with pharmaceutical and biotech companies.
"We are very proud of this investment that recognizes the power of pharmacogenomics as a tool for improving the health of the population," said Paul L'Archevêque, president and CEO of Génome Québec. "This project is the result of efforts that Génome Québec undertook in 2006, with the recruitment of scientist Michael Phillips and the creation of the Génome Québec and Montreal Heart Institute Pharmacogenomics Centre.”

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.